Health & Fitness
Health and Fitness
Health and Fitness
Thu, September 23, 2010
[ Thu, Sep 23rd 2010
] - Market Wire
[ Thu, Sep 23rd 2010
] - Market Wire
[ Thu, Sep 23rd 2010
] - Market Wire
[ Thu, Sep 23rd 2010
] - Market Wire
[ Thu, Sep 23rd 2010
] - Market Wire
[ Thu, Sep 23rd 2010
] - Market Wire
[ Thu, Sep 23rd 2010
] - Market Wire
[ Thu, Sep 23rd 2010
] - Market Wire
[ Thu, Sep 23rd 2010
] - Market Wire
[ Thu, Sep 23rd 2010
] - Market Wire
[ Thu, Sep 23rd 2010
] - Market Wire
[ Thu, Sep 23rd 2010
] - Market Wire
[ Thu, Sep 23rd 2010
] - Market Wire
Wed, September 22, 2010
[ Wed, Sep 22nd 2010
] - Market Wire
[ Wed, Sep 22nd 2010
] - Market Wire
[ Wed, Sep 22nd 2010
] - Market Wire
[ Wed, Sep 22nd 2010
] - Market Wire
[ Wed, Sep 22nd 2010
] - Market Wire
ANGIOTECH ANNOUNCES STRONG OUTCOMES IN DIABETIC PATIENTS TREATED WITH BOSTON SCIENTIFIC CORPORATION';S PLATINUM CHROMIUM TAXUS(
Forward Looking Statements --------------------------
--------------------- (1) Academic Research Consortium (2) The TAXUS Express and TAXUS Liberté Stent Systems are not specifically indicated for diabetic patients in the U.S. (3) Based on bench testing. Data on file with Boston Scientific. (4) The TAXUS Element Stent System will be commercialized as the ION(TM) Paclitaxel-Eluting Platinum Chromium Coronary Stent System in the U.S.
Contributing Sources
